{"product_id":"cardiac-resynchronization-therapy-profitability","title":"How Increase Profits Cardiac Resynchronization Therapy Services?","description":"\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"line_top\"\u003e\u003c\/div\u003e\n\u003ch2\u003eCardiac Resynchronization Therapy Services Strategies to Increase Profitability\u003c\/h2\u003e\n\u003cp\u003eMost Cardiac Resynchronization Therapy Services can achieve EBITDA margins between 65% and 75% by focusing on physician capacity and supply chain leverage this model breaks even in Month 1\n\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\" id=\"main_article_image\"\u003e\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #6067F2;\"\u003e7 Strategies to Increase Profitability of \u003c\/span\u003eCardiac Resynchronization Therapy Services\u003c\/h2\u003e\u003cbr\u003e\n\u003ctable id=\"dwnld_tbl_id\"\u003e\n\u003ctr\u003e\n\u003cth\u003e#\u003c\/th\u003e\n\u003cth\u003eStrategy\u003c\/th\u003e\n\u003cth\u003eProfit Lever\u003c\/th\u003e\n\u003cth\u003eDescription\u003c\/th\u003e\n\u003cth\u003eExpected Impact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e1\u003c\/td\u003e\n\u003ctd\u003eEP Utilization Boost\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eIncrease Senior Electrophysiologist utilization from 650% in 2026 toward 900% by 2030 to capture more procedure revenue.\u003c\/td\u003e\n\u003ctd\u003eMaximizes revenue capture on $45,000 procedures.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e2\u003c\/td\u003e\n\u003ctd\u003eDevice Cost Reduction\u003c\/td\u003e\n\u003ctd\u003eCOGS\u003c\/td\u003e\n\u003ctd\u003eDrive CRT Device and Lead Kit cost down from 120% of revenue in 2026 to 100% of revenue by 2030.\u003c\/td\u003e\n\u003ctd\u003eDirectly increases gross margin by 2 percentage points.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e3\u003c\/td\u003e\n\u003ctd\u003eBilling Fee Reduction\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eLower Medical Billing and Collection Fees from 40% of revenue in 2026 to 30% by 2030.\u003c\/td\u003e\n\u003ctd\u003eSaves over $93,830 in Year 1 alone.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e4\u003c\/td\u003e\n\u003ctd\u003eFacility Fee Negotiation\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eReduce Catheterization Lab Facility Fees from 50% of revenue in 2026 to 40% through higher volume contracts.\u003c\/td\u003e\n\u003ctd\u003eSaves $93,830 in 2026.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e5\u003c\/td\u003e\n\u003ctd\u003eMid-Level Capacity Use\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eEnsure Nurse Practitioners and Cardiac Device Specialists maximize their 70%+ capacity for efficient follow-up care.\u003c\/td\u003e\n\u003ctd\u003eImproves efficiency in handling high-volume follow-up care.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e6\u003c\/td\u003e\n\u003ctd\u003eTech Efficiency Gain\u003c\/td\u003e\n\u003ctd\u003eProductivity\u003c\/td\u003e\n\u003ctd\u003eIncrease Remote Monitoring Technician output from 200 treatments\/month in 2026 to 250 treatments\/month by 2030.\u003c\/td\u003e\n\u003ctd\u003eImproves labor efficiency defintely.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e7\u003c\/td\u003e\n\u003ctd\u003eReferral Cost Focus\u003c\/td\u003e\n\u003ctd\u003eOPEX\u003c\/td\u003e\n\u003ctd\u003eCut Referral Network Outreach costs from 30% of revenue in 2026 to 15% by focusing only on high-converting sources.\u003c\/td\u003e\n\u003ctd\u003eHalves the percentage of revenue spent on referral outreach.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"dwnld_btn_div\"\u003e\u003cbutton id=\"dwnld_btn_id\" class=\"dwnld_btn_clss\"\u003eDownload Table in XLSX\u003c\/button\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhat is our true contribution margin per procedure type, factoring in variable COGS?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour true contribution margin is split: high-value CRT implantations generate the bulk of the profit, but lower-priced monitoring services are essential for keeping your specialized labor busy, defintely. If you focus only on the \u003cstrong\u003e$45,000\u003c\/strong\u003e procedures, you miss the efficiency gained by utilizing staff during the \u003cstrong\u003e$95\u003c\/strong\u003e monitoring volume.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eProfit Drivers: High-Ticket Implants\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCRT procedure Average Order Value (AOV) sits at \u003cstrong\u003e$45,000\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThese procedures carry the highest potential gross margin per service.\u003c\/li\u003e\n\u003cli\u003eThey are the primary source funding your specialized fixed overhead.\u003c\/li\u003e\n\u003cli\u003eOverall business profitability hinges on achieving target volumes here.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eVolume \u0026amp; Utilization: Monitoring Role\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMonitoring services show a low AOV of just \u003cstrong\u003e$95\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThese low-ticket jobs fill gaps in the specialist practitioner schedule.\u003c\/li\u003e\n\u003cli\u003eThey help cover fixed labor costs when implants are less frequent.\u003c\/li\u003e\n\u003cli\u003eUnderstanding the full startup cost helps model this balance; see \u003ca href=\"\/blogs\/startup-costs\/cardiac-resynchronization-therapy\"\u003eHow Much To Start Cardiac Resynchronization Therapy Services Business?\u003c\/a\u003e for initial planning.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eHow fast can we increase electrophysiologist capacity utilization to meet demand?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eThe fastest way to scale capacity for Cardiac Resynchronization Therapy Services is by aggressively increasing Senior Electrophysiologist utilization from the starting point of \u003cstrong\u003e650%\u003c\/strong\u003e toward a target of \u003cstrong\u003e900%\u003c\/strong\u003e by 2030, since these specialists drive the high-value procedure revenue. This focus is critical for maximizing throughput, as detailed in metrics like \u003ca href=\"\/blogs\/kpi-metrics\/cardiac-resynchronization-therapy\"\u003eWhat Are The 5 KPI Metrics For Cardiac Resynchronization Therapy Services Business?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUtilization Baseline \u0026amp; Growth Path\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSenior Electrophysiologists (EPs) start at \u003cstrong\u003e650%\u003c\/strong\u003e utilization.\u003c\/li\u003e\n\u003cli\u003eThis high initial utilization means scheduling is already dense.\u003c\/li\u003e\n\u003cli\u003eWe need to defintely map barriers preventing \u003cstrong\u003e800%\u003c\/strong\u003e utilization next year.\u003c\/li\u003e\n\u003cli\u003eFocus on reducing administrative drag on the EP's time now.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Impact of Capacity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eGrowth hinges on reaching \u003cstrong\u003e900%\u003c\/strong\u003e utilization by 2030.\u003c\/li\u003e\n\u003cli\u003eThe high revenue per procedure makes EPs the primary revenue driver.\u003c\/li\u003e\n\u003cli\u003eEvery percentage point gain directly boosts top-line revenue.\u003c\/li\u003e\n\u003cli\u003eOptimize referral flow from primary care physicians to feed specialist capacity.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eAre our device procurement costs competitive relative to projected scaling volume?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eYour device procurement costs are not competitive; the cost of CRT Device and Lead Kits currently represents \u003cstrong\u003e120% of 2026 revenue\u003c\/strong\u003e, meaning small cuts yield massive dollar savings directly impacting your gross margin, a key area to model when you \u003ca href=\"\/blogs\/write-business-plan\/cardiac-resynchronization-therapy\"\u003eHow To Write A Business Plan For Cardiac Resynchronization Therapy Services?\u003c\/a\u003e\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost Overhang\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eThe cost structure shows CRT Device and Lead Kits are \u003cstrong\u003e120%\u003c\/strong\u003e of projected 2026 revenue.\u003c\/li\u003e\n\u003cli\u003eThis implies that without immediate negotiation, the Cardiac Resynchronization Therapy Services model loses money on every procedure.\u003c\/li\u003e\n\u003cli\u003eGross margin improvement is entirely dependent on driving down this input cost; it's the main lever.\u003c\/li\u003e\n\u003cli\u003eYou must secure better pricing now; defintely do not wait for volume to increase before negotiating.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eModel the effect of a \u003cstrong\u003e10%\u003c\/strong\u003e reduction in device cost immediately.\u003c\/li\u003e\n\u003cli\u003eA 10% cost cut translates to a huge percentage swing in your overall operating profit.\u003c\/li\u003e\n\u003cli\u003eFocus procurement efforts on the lead kits, as they often have more supplier flexibility.\u003c\/li\u003e\n\u003cli\u003eUse projected 2026 volume to negotiate bulk commitments starting Q3 2024.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003e\u003cspan style=\"color: #126CFF;\"\u003eWhere can we safely automate remote monitoring without compromising patient care quality?\n\u003c\/span\u003e\u003c\/h2\u003e\n\u003cp\u003eAutomation in Cardiac Resynchronization Therapy Services should focus on scaling technician capacity beyond the projected \u003cstrong\u003e200 treatments\/month in 2026\u003c\/strong\u003e by standardizing data review processes, not by replacing direct patient interaction; understanding this operational leverage is key to your \u003ca href=\"\/blogs\/write-business-plan\/cardiac-resynchronization-therapy\"\u003eHow To Write A Business Plan For Cardiac Resynchronization Therapy Services?\u003c\/a\u003e. You've got to get the utilization right, or technician costs will eat your margins.\u003c\/p\u003e\n\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMaximizing Technician Capacity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTarget \u003cstrong\u003e200 treatments\/month\u003c\/strong\u003e volume handled by technicians in 2026.\u003c\/li\u003e\n\u003cli\u003eEfficiency gains must directly improve labor utilization rates.\u003c\/li\u003e\n\u003cli\u003eAutomate routine data flagging; don't automate interpretation.\u003c\/li\u003e\n\u003cli\u003eWe defintely need to cut down manual data aggregation time.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eProtecting Care Quality Boundaries\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eSpecialized focus on CRT must remain uncompromised.\u003c\/li\u003e\n\u003cli\u003eAvoid automating the final specialist interpretation of device data.\u003c\/li\u003e\n\u003cli\u003eProcedural success relies on high-touch specialist skill.\u003c\/li\u003e\n\u003cli\u003eIf remote setup takes longer than \u003cstrong\u003e48 hours\u003c\/strong\u003e, patient satisfaction drops.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\n\n\u003cdiv class=\"double_border\"\u003e\n\n\u003cdiv class=\"card_smpl_header\"\u003e\n\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-plus-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\n\n\u003ch3\u003eKey Takeaways\u003c\/h3\u003e\n\n\u003c\/div\u003e\n\n\u003cul class=\"lst_crct_blog\"\u003e\n\n\u003cli\u003eAchieving target EBITDA margins between 65% and 75% relies fundamentally on maximizing physician utilization and aggressively negotiating supply chain costs.\u003c\/li\u003e\n\n\u003cli\u003eThe primary growth lever involves scaling Senior Electrophysiologist capacity utilization from the starting 650% toward a target of 900% to maximize high-value $45,000 procedures.\u003c\/li\u003e\n\n\u003cli\u003eImmediate profitability is achievable, with the financial model projecting a complete breakeven point within the first month of operation.\u003c\/li\u003e\n\n\u003cli\u003eControlling the largest variable cost driver, CRT Device and Lead Kits (initially 120% of revenue), through procurement leverage directly translates into significant gross margin improvement.\u003c\/li\u003e\n\n\u003c\/ul\u003e\n\n\u003c\/div\u003e\n\n\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 1\n: \u003cspan style=\"color: #126CFF;\"\u003eMaximize EP Utilization\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBoost EP Time\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003ePushing Senior Electrophysiologist utilization from \u003cstrong\u003e650% in 2026\u003c\/strong\u003e up to \u003cstrong\u003e900% by 2030\u003c\/strong\u003e directly captures more revenue from every \u003cstrong\u003e$45,000\u003c\/strong\u003e Cardiac Resynchronization Therapy (CRT) case. This means scheduling efficiency is the main driver for margin expansion here.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eScheduling Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eUtilization measures time spent on billable procedures versus available time. Hitting \u003cstrong\u003e900% utilization\u003c\/strong\u003e requires tight scheduling inputs: procedure duration, OR block time, and patient lag time. If an EP bills 6.5 procedures daily (650%), moving to 9 (900%) means finding \u003cstrong\u003e2.5 extra slots\u003c\/strong\u003e daily. This is defintely achievable with better logistics.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMeasure time per procedure precisely.\u003c\/li\u003e\n\u003cli\u003eEnsure OR turnover is fast.\u003c\/li\u003e\n\u003cli\u003eSchedule follow-ups off-peak.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eUtilization Levers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIncreasing utilization from \u003cstrong\u003e650% to 900%\u003c\/strong\u003e isn't just about booking more cases; it's optimizing the $45k procedure flow. You must reduce non-productive time, like case setup or documentation delays, which erode billable hours. If you shave 30 minutes off the average procedure time, that opens capacity for nearly \u003cstrong\u003eone extra case weekly\u003c\/strong\u003e per EP.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eReduce EP documentation time by 20%.\u003c\/li\u003e\n\u003cli\u003eStandardize device setup protocols.\u003c\/li\u003e\n\u003cli\u003eImprove referral conversion speed.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eRevenue Capture Gap\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe gap between \u003cstrong\u003e650% and 900% utilization\u003c\/strong\u003e represents significant untapped revenue potential on the \u003cstrong\u003e$45,000\u003c\/strong\u003e average procedure price. If you have 10 EPs, closing this 250 percentage point gap means capturing revenue equivalent to \u003cstrong\u003e6.25 full-time EPs\u003c\/strong\u003e worth of procedures annually, assuming consistent case volume targets.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 2\n: \u003cspan style=\"color: #126CFF;\"\u003eNegotiate Down Device COGS\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Device Cost to 100% Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLowering the cost of CRT Devices and Lead Kits from \u003cstrong\u003e120% of revenue\u003c\/strong\u003e in 2026 to \u003cstrong\u003e100%\u003c\/strong\u003e by 2030 directly boosts your gross margin by \u003cstrong\u003e2 percentage points\u003c\/strong\u003e. This cost reduction is critical for scaling profitability in your specialized service model.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat Device COGS Covers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eDevice COGS covers the actual hardware-the \u003cstrong\u003eCRT Device and Lead Kits\u003c\/strong\u003e-used in every implantation procedure. To model this, you need supplier quotes multiplied by projected annual unit volume. In 2026, this cost eats up \u003cstrong\u003e120% of revenue\u003c\/strong\u003e, meaning you lose money on the device alone before factoring in labor or facility fees.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eNegotiate Device Pricing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must negotiate better pricing as volume increases. Leverage projected growth to secure better tier pricing from medical suppliers. A common mistake is accepting initial quotes without aggressive negotiation. Aiming for \u003cstrong\u003e100% of revenue\u003c\/strong\u003e by 2030 is achievable if you commit to volume-based discounts now, defintely.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eDemand volume tiers based on 2030 projections.\u003c\/li\u003e\n\u003cli\u003eBenchmark against other high-volume centers.\u003c\/li\u003e\n\u003cli\u003eTie payment terms to utilization rates.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Impact of Success\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eHitting the \u003cstrong\u003e100% COGS target\u003c\/strong\u003e means the device cost matches revenue for that component, neutralizing the initial loss. Every dollar saved below that 100% line flows straight to the bottom line, significantly improving your overall financial health starting in 2027.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 3\n: \u003cspan style=\"color: #126CFF;\"\u003eOptimize Billing \u0026amp; Collections\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Billing Fees Now\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must aggressively cut third-party billing costs to boost profitability immediately. Targeting a reduction in Medical Billing and Collection Fees from \u003cstrong\u003e40% in 2026\u003c\/strong\u003e down to \u003cstrong\u003e30% by 2030\u003c\/strong\u003e frees up significant cash. This operational fix saves you over \u003cstrong\u003e$93,830 in Year 1\u003c\/strong\u003e alone, which is pure margin improvement.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBilling Fee Cost Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis 40% fee covers Revenue Cycle Management (RCM), meaning coding, claim submission to payers, and collections follow-up. Inputs are your total procedure revenue (procedures times the $45,000 price point) multiplied by the 40% service charge. Honestly, this is a huge overhead line item draining cash flow from your Cardiac Resynchronization Therapy services.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eProcedure Revenue × 40% Fee Rate.\u003c\/li\u003e\n\u003cli\u003eCovers all billing overhead.\u003c\/li\u003e\n\u003cli\u003eBased on $45,000 average procedure price.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eReducing Collection Overhead\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eReducing this 40% fee requires moving away from high-cost third-party RCM firms toward in-house capabilities or negotiating vendor rates based on performance. High denial rates inflate vendor percentages because they have to work harder to collect. You need clean claims upfront to get better rates; this is defintely achievable.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eNegotiate vendor contracts on net collections.\u003c\/li\u003e\n\u003cli\u003eInvest in internal pre-authorization staff.\u003c\/li\u003e\n\u003cli\u003eBenchmark against 25% industry average costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFocus on Year 1 Savings\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThe immediate win comes from focusing on Year 1 savings, not just the 2030 goal. That initial \u003cstrong\u003e$93,830\u003c\/strong\u003e saved by shaving just a few points off the 40% rate should be reinvested directly into improving internal compliance or hiring better pre-authorization staff. That's smart money management for a growing practice.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 4\n: \u003cspan style=\"color: #126CFF;\"\u003eControl Cath Lab Fees\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Lab Fees Now\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eReducing facility fees is critical for margin expansion. You must drive the Catheterization Lab Facility Fees share down from \u003cstrong\u003e50%\u003c\/strong\u003e of revenue in 2026 to \u003cstrong\u003e40%\u003c\/strong\u003e by 2030. This shift, achieved via better volume deals, nets you \u003cstrong\u003e$93,830\u003c\/strong\u003e in savings next year alone.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWhat Facility Fees Cover\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eFacility fees cover the overhead of using the specialized Catheterization Lab space and equipment for the implantation procedure. This cost is calculated as a percentage of total revenue, pegged at \u003cstrong\u003e50%\u003c\/strong\u003e in 2026. Inputs are procedure volume and the negotiated rate structure tied to that volume.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eNegotiate Volume Tiers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou control this cost by increasing procedure volume to gain leverage in contract negotiations with the facility owner. Aim to lock in tiered pricing that rewards higher annual case counts. It's simple math; more cases mean lower per-case facility overhead.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eMargin Impact\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eLowering facility fees directly boosts your gross margin, which is essential when device COGS is still high at \u003cstrong\u003e120%\u003c\/strong\u003e of revenue in 2026. Every percentage point saved here flows straight to the bottom line, improving cash flow faster than revenue growth alone.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 5\n: \u003cspan style=\"color: #126CFF;\"\u003eScale Mid-Level Volume\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eHit Mid-Level Targets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYour mid-level staff, Nurse Practitioners and Cardiac Device Specialists, must hit \u003cstrong\u003e70% utilization\u003c\/strong\u003e managing follow-up care. This efficiency directly supports scaling the entire practice volume without over-relying on highly paid specialists for routine checks.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eTrack Follow-Up Load\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eEffective utilization of NPs and CDSs handles routine patient monitoring and device checks. This requires tracking their daily appointment slots versus actual completed follow-up visits. High utilization means fewer bottlenecks delaying the primary procedure schedule.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eMeasure billable follow-up volume daily.\u003c\/li\u003e\n\u003cli\u003eEnsure scheduling accounts for device complexity.\u003c\/li\u003e\n\u003cli\u003eTrack time spent on non-billable admin tasks.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDrive Staff Efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo ensure staff hit that \u003cstrong\u003e70%+ capacity\u003c\/strong\u003e, standardize follow-up protocols across the practice. Avoid letting complex documentation eat into clinical time. If a CDS has 40 available follow-up slots per week, you must aim for \u003cstrong\u003e28\u003c\/strong\u003e billable visits minimum to justify the fixed labor cost.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eCreate templated post-op checks.\u003c\/li\u003e\n\u003cli\u003eCross-train staff on basic device troubleshooting.\u003c\/li\u003e\n\u003cli\u003eReview scheduling buffers weekly for waste.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eWatch Utilization Lag\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf onboarding new patients or device programming takes longer than expected, utilization drops fast. If utilization falls below \u003cstrong\u003e70%\u003c\/strong\u003e, you lose the operational leverage needed to support growth in high-revenue implant procedures, forcing you to pay specialists for downtime.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 6\n: \u003cspan style=\"color: #126CFF;\"\u003eStreamline Monitoring Load\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eBoost Tech Output\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must lift Remote Monitoring Technician output from \u003cstrong\u003e200 treatments\/month\u003c\/strong\u003e in 2026 to \u003cstrong\u003e250 treatments\/month\u003c\/strong\u003e by 2030. This \u003cstrong\u003e25% efficiency gain\u003c\/strong\u003e directly lowers your cost per patient touchpoint, improving labor efficiency defintely. It means fewer techs needed for the same patient load as you scale.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eLabor Cost Input\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTechnician labor cost depends on fully loaded salary and benefits per person. To model the savings, multiply the target efficiency gain (\u003cstrong\u003e50 treatments\/tech\u003c\/strong\u003e) by the number of technicians required at the 2026 baseline. You need the \u003cstrong\u003efully loaded annual salary\u003c\/strong\u003e for one technician to quantify the savings from this \u003cstrong\u003e25% volume increase\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTechnician fully loaded annual salary\u003c\/li\u003e\n\u003cli\u003eCurrent 2026 technician count\u003c\/li\u003e\n\u003cli\u003eTarget 2030 technician count\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eDrive Tech Throughput\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eAchieving \u003cstrong\u003e250 treatments\/month\u003c\/strong\u003e requires process hardening, not just faster typing. Standardize the review protocol for every remote monitoring check. Invest in software that auto-flags high-risk cases, letting techs focus their time where clinical judgment is essential. Avoid letting techs handle scheduling.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eStandardize remote review workflows\u003c\/li\u003e\n\u003cli\u003eAutomate low-risk alert triage\u003c\/li\u003e\n\u003cli\u003eTrain on new device alert systems\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eEfficiency Lever\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eIf you don't hit \u003cstrong\u003e250 treatments\/tech\u003c\/strong\u003e, scaling procedure volume means hiring support staff linearly, crushing your margin profile. This labor leverage is critical for supporting higher EP utilization (Strategy 1) without ballooning overhead.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\n\u003ch2\u003eStrategy 7\n: \u003cspan style=\"color: #126CFF;\"\u003eFocus Referral Outreach\n\u003c\/span\u003e\n\u003c\/h2\u003e\u003cbr\u003e\n\u003cdiv class=\"card_smpl blue_card\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-colons-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCut Outreach Spend\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eYou must cut referral outreach spending from \u003cstrong\u003e30% of revenue\u003c\/strong\u003e in 2026 down to \u003cstrong\u003e15% by 2030\u003c\/strong\u003e. This requires rigorously tracking which referring cardiologists and primary care physicians actually convert into paying procedures. Stop spending money on sources that don't deliver volume.\u003c\/p\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"container_2_clmn_row\"\u003e\n\u003cdiv class=\"card_smpl_2\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-tips-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eCost Inputs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eThis cost covers marketing, relationship management, and travel aimed at securing patient referrals from other doctors. You need to track total outreach spend against realized procedure volume from those specific sources. The 2026 baseline is \u003cstrong\u003e30% of revenue\u003c\/strong\u003e for this activity.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eTrack total outreach spend.\u003c\/li\u003e\n\u003cli\u003eMeasure resulting procedure volume.\u003c\/li\u003e\n\u003cli\u003eBaseline is 30% cost ratio (2026).\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"card_smpl\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-intro-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eOptimization Tactics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eTo hit the \u003cstrong\u003e15% target\u003c\/strong\u003e, stop broad outreach and double down on proven referrers. Analyze conversion rates per source; if one group sends 5 patients and another sends 50, shift resources there. A defintely better approach is focusing on quality leads.\u003c\/p\u003e\n\u003cul class=\"lst_crct_blog\"\u003e\n\u003cli\u003eAudit referral source conversion.\u003c\/li\u003e\n\u003cli\u003eReallocate budget to top performers.\u003c\/li\u003e\n\u003cli\u003eTarget 50% cost reduction by 2030.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003e\u003cdiv class=\"card_smpl\"\u003e\u003cdiv class=\"double_border\"\u003e\n\u003cdiv class=\"card_smpl_header\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/fml_20_fml-20-blog-pin-icon.svg\" alt=\"Icon\" class=\"icon_how_to_use\"\u003e\u003ch3\u003eFocus Leverage\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cp\u003eHigh-converting sources likely require less direct sales time once established. Focus technician and specialist time on nurturing relationships with the top \u003cstrong\u003e20% of referrers\u003c\/strong\u003e who drive 80% of your volume. This operational shift supports the financial goal.\u003c\/p\u003e\n\u003c\/div\u003e\u003c\/div\u003e\u003cbr\u003e\u003cbr\u003e\u003cbr\u003e","brand":"FinancialModelsLab","offers":[{"title":"Default Title","offer_id":49303484629235,"sku":"cardiac-resynchronization-therapy-profitability","price":0.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0522\/6191\/2762\/files\/cardiac-resynchronization-therapy-profitability.webp?v=1782678002","url":"https:\/\/financialmodelslab.com\/products\/cardiac-resynchronization-therapy-profitability","provider":"Financial Models Lab","version":"1.0","type":"link"}